We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
276
Goldman Sachs
GS
$313B
$4.2M 0.08%
18,274
-3,338
-15% -$806K
SPG icon
277
Simon Property Group
SPG
$74.5B
$4.19M 0.08%
24,367
+343
+1% +$61.3K
NBL
278
DELISTED
Noble Energy, Inc.
NBL
$4.14M 0.08%
120,640
+38,652
+47% +$1.43M
SUPN icon
279
Supernus Pharmaceuticals
SUPN
$2.68B
$4.13M 0.08%
132,000
+45,000
+52% +$1.21M
EQT icon
280
EQT Corp
EQT
$33.2B
$4.09M 0.08%
123,011
+16,961
+16% +$566K
ARRY
281
DELISTED
Array Biopharma Inc
ARRY
$4.07M 0.08%
455,000
-300,000
-40% -$3.19M
AUY
282
DELISTED
Yamana Gold, Inc.
AUY
$4.03M 0.08%
1,462,763
-805,429
-36% -$2.44M
BIDU icon
283
Baidu
BIDU
$35.8B
$4.02M 0.08%
23,325
-1,300
-5% -$229K
KHC icon
284
Kraft Heinz
KHC
$30.4B
$4.02M 0.08%
44,217
+5,645
+15% +$509K
BBBY
285
DELISTED
Bed Bath & Beyond Inc
BBBY
$4M 0.08%
101,226
+38,117
+60% +$1.53M
OGE icon
286
OGE Energy
OGE
$10.3B
$3.99M 0.08%
114,172
+9,744
+9% +$339K
WMB icon
287
Williams Companies
WMB
$90.5B
$3.99M 0.08%
134,943
+98,086
+266% +$2.84M
EGRX
288
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.98M 0.08%
48,000
-14,000
-23% -$1.04M
RTN
289
DELISTED
Raytheon Company
RTN
$3.96M 0.08%
25,993
+5,715
+28% +$860K
LVLT
290
DELISTED
Level 3 Communications Inc
LVLT
$3.94M 0.08%
68,792
+6,605
+11% +$381K
ITW icon
291
Illinois Tool Works
ITW
$81.4B
$3.89M 0.08%
29,370
+5,094
+21% +$659K
NEE icon
292
NextEra Energy
NEE
$187B
$3.88M 0.08%
121,024
+23,192
+24% +$729K
GXP
293
DELISTED
Great Plains Energy Incorporated
GXP
$3.88M 0.08%
132,618
-47,828
-27% -$1.34M
SPGI icon
294
S&P Global
SPGI
$126B
$3.84M 0.07%
29,344
+9,551
+48% +$1.19M
AIG icon
295
American International
AIG
$41.9B
$3.82M 0.07%
+61,213
New +$3.93M
GGP
296
DELISTED
GGP Inc.
GGP
$3.82M 0.07%
164,883
+113,308
+220% +$2.77M
BNS icon
297
Scotiabank
BNS
$106B
$3.8M 0.07%
65,083
+6,680
+11% +$397K
DDC
298
DELISTED
Dominion Diamond Corporation
DDC
$3.79M 0.07%
+300,000
New +$3.03M
GAP
299
The Gap Inc
GAP
$6.84B
$3.77M 0.07%
155,126
-124,621
-45% -$2.98M
MDCO
300
DELISTED
Medicines Co
MDCO
$3.77M 0.07%
77,000
-26,000
-25% -$1.19M
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.